tirzepatide and eye issues Study link: https://www.ajo.com/article/S0002-9394(25)00653-1/abstract, #glaucoma #eye #glp1 #glp #thelovingdiet Tirzepatide and Macular Degeneration: Current

Semaglutide mimics that hormone but lasts much longer in the bloodstream, roughly seven days compared to the minutes a natural GLP-1 molecule survives

Auranofin mitigates systemic iron overload and induces ferroptosis via distinct mechanisms

According to guidance from the European Medicines Agency, a margin of 0.3% is generally considered acceptable, although it is subject to change based on the clinical context

Fifty or more percent of patients treated with immune checkpoint inhibitors experience some side effects, from rash and local inflammation that can be treated with steroids and/or by temporarily discontinuing the treatment, to severe side effects, such as type 1 diabetes (T1D), thyroid and cardiac issues